Status:
UNKNOWN
Clinical Performance of Withings Move ECG Software for Atrial Fibrillation Detection
Lead Sponsor:
Withings
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Withings Move ECG watch is designed to record ECG and detect automatically atrial fibrillation. The aim of this study is to validate the performance of Move ECG watch to detect atrial fibrillation com...
Detailed Description
Patients with atrial fibrillation are included in hospitals. On each patient, ECG with Move ECG and the reference 12-lead ECG are recorded simultaneously. Both records are then reviewed by independent...
Eligibility Criteria
Inclusion
- male or female who are 18 years or older
- Subject who signed the written informed consent form
Exclusion
- Vulnerable subject with regard to regulations
- Pregnant, parturient or breastfeeding woman,
- Subject who is deprived of liberty by judicial, medical or administrative decision,
- Underage subject,
- Legally protected subject, or subject who is unable to sign the written informed consent form,
- Subject who is not beneficiary or not affiliated to a social security scheme,
- Subject within several of the above categories,
- Subject who refused to participate in the study,
- Subject in physical incapacity to wear a wrist-worn watch
- Subject with electrical stimulation by pacemaker
Key Trial Info
Start Date :
December 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 15 2020
Estimated Enrollment :
234 Patients enrolled
Trial Details
Trial ID
NCT04493749
Start Date
December 20 2019
End Date
October 15 2020
Last Update
July 30 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Cœur Paris Centre Turin
Paris, Île-de-France Region, France, 75008
2
Hopital Europeen Georges Pompidou
Paris, Île-de-France Region, France, 75015
3
Centre Cardiologique du Nord
Saint-Denis, Île-de-France Region, France, 93200